PSA Doubling Time and Absolute PSA Predict Metastasis-free Survival in Men With Biochemically Recurrent Prostate Cancer After Radical Prostatectomy-Reference-Cited by-同舟云学术

PSA Doubling Time and Absolute PSA Predict Metastasis-free Survival in Men With Biochemically Recurrent Prostate Cancer After Radical Prostatectomy

Published:2019-12 Issue:6 Volume:17 Page:470-475.e1
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Markowski Mark C.,Chen Yongmei,Feng Zhaoyong,Cullen Jennifer,Trock Bruce J.,Suzman Daniel,Antonarakis Emmanuel S.,Paller Channing J.,Rosner Inger,Han Misop,Walsh Patrick C.,Partin Alan W.,Eisenberger Mario

Funder

Sidney Kimmel Comprehensive Cancer Center

Johns Hopkins

National Institutes of Health

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference23 articles.

1. Cancer statistics, 2018;Siegel;CA Cancer J Clin,2018

2. Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control;Pound;Urol Clin North Am,1997

3. Radical prostatectomy for clinically localized prostate cancer: long-term results of 1,143 patients from a single institution;Zincke;J Clin Oncol,1994

4. The incidence and significance of detectable levels of serum prostate specific antigen after radical prostatectomy;Trapasso;J Urol,1994

5. Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy;Trock;JAMA,2008

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Olaparib Without Androgen Deprivation for High-Risk Biochemically Recurrent Prostate Cancer Following Prostatectomy;JAMA Oncology;2024-08-22

2. Usefulness of Tissue Biomarkers versus Prostate-Specific Membrane Antigen-Positron Emission Tomography for Prostate Cancer Biochemical Recurrence after Radical Prostatectomy;Cancers;2024-08-19

3. Salvage Reirradiation for Locally Recurrent Prostate Cancer: Results From a Prospective Study With 7.2 Years of Follow-Up;Journal of Clinical Oncology;2024-06-01

4. Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part II: Treatment Delivery for Non-metastatic Biochemical Recurrence After Primary Radical Prostatectomy;Journal of Urology;2024-04

5. Predictive Value of the Prostate-Specific Antigen Doubling Time for the Effectiveness of Metastasis-Directed Radiotherapy in Patients with Oligometastases after Radical Treatment for Non-metastatic Prostate Cancer: A Single Institution Retrospective Study;2024-03-19